$24.33
0.26 (+1.08%)
Par Pharmaceutical Companies, Inc. (PRX)
CAPS Rating:
The Company, through its subsidiary Par Pharmaceutical, Inc., is engaged in the development, manufacture and distribution of generic pharmaceuticals and branded pharmaceuticals in the United States.

RSS Headlines
Fool UK